Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis
- PMID: 12735999
- DOI: 10.1016/s0090-4295(02)02597-9
Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis
Abstract
Objectives: Interstitial cystitis (IC) is a chronic bladder disorder for which the etiology is unknown. We have previously shown that antiproliferative factor (APF), heparin-binding epidermal growth factor-like growth factor (HB-EGF), and epidermal growth factor (EGF) are sensitive and specific biomarkers for IC in white American patients. Because little is known about the epidemiology of this disorder, it is unclear whether these factors would also be useful biomarkers for IC in patients from different racial groups and/or geographic locations.
Methods: Urine specimens were collected from Chinese, white American, and African-American women with IC and age and race-matched asymptomatic normal control women. APF activity was determined by (3)H-thymidine incorporation into primary normal adult human bladder epithelial cells in vitro. The HB-EGF and EGF urine levels were determined by enzyme-linked immunosorbent assay.
Results: The Chinese, African-American, and white American women with IC had significantly greater urine APF activity (P <0.000001, P = 0.0008, and P <0.000001, respectively), lower urine HB-EGF levels (P <0.000001, P = 0.02, and P <0.000001, respectively), and greater urine EGF levels (P <0.000001, P = 0.002, and P <0.000001, respectively), than their matched asymptomatic controls.
Conclusions: These findings confirm the utility of APF, HB-EGF, and EGF as biomarkers for IC in patients from three different racial groups and two different countries.
Similar articles
-
Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome.Urology. 2004 Jan;63(1):22-6. doi: 10.1016/j.urology.2003.08.024. Urology. 2004. PMID: 14751340
-
Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis.Urology. 2001 Jun;57(6 Suppl 1):9-14. doi: 10.1016/s0090-4295(01)01127-x. Urology. 2001. PMID: 11378043
-
APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.BMC Urol. 2005 Apr 29;5:7. doi: 10.1186/1471-2490-5-7. BMC Urol. 2005. PMID: 15862132 Free PMC article.
-
Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).Georgian Med News. 2014 Jul-Aug;(232-233):12-5. Georgian Med News. 2014. PMID: 25214264 Review.
-
Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.Int J Urol. 2014 Apr;21 Suppl 1:34-41. doi: 10.1111/iju.12311. Int J Urol. 2014. PMID: 24807491 Review.
Cited by
-
Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.BMC Urol. 2023 Nov 8;23(1):180. doi: 10.1186/s12894-023-01353-z. BMC Urol. 2023. PMID: 37940904 Free PMC article.
-
Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.Asia Pac J Ophthalmol (Phila). 2022 Mar-Apr 01;11(2):100-110. doi: 10.1097/APO.0000000000000504. Asia Pac J Ophthalmol (Phila). 2022. PMID: 35533330 Free PMC article. Review.
-
Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.Diagnostics (Basel). 2021 Nov 30;11(12):2238. doi: 10.3390/diagnostics11122238. Diagnostics (Basel). 2021. PMID: 34943475 Free PMC article. Review.
-
A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.BMC Urol. 2012 Jun 8;12:17. doi: 10.1186/1471-2490-12-17. BMC Urol. 2012. PMID: 22682521 Free PMC article.
-
Combination of MS protein identification and bioassay of chromatographic fractions to identify biologically active substances from complex protein sources.Mol Cell Proteomics. 2009 Jun;8(6):1318-23. doi: 10.1074/mcp.M800491-MCP200. Epub 2009 Feb 3. Mol Cell Proteomics. 2009. PMID: 19193608 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical